RxDoctor Payments Data

Katherine Hammerschmidt, APRN

Adult Health · Saint Louis, MONPI 1922517747

Payments from drug & device makers

$1,224in general payments, 2019–2025

Across 60 payments — averaging $20.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$500
  • AstraZeneca$167
  • Novo Nordisk$158
  • GSK$129
  • Pfizer$80
  • Ipsen Biopharmaceuticals, Inc$49
  • plus $140 from 5 others

What the payments were for

  • Food & beverage$1,224100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,224 in reported general payments places this provider in the 65th percentile of 555 adult health providers in Missouri.

See all adult health providers in Missouri

Medicare billing

Part B allowed, 2024
$21,592
Medicare patients
140
Services billed
317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin21$21,808
EliquisApixaban26$19,603
Breo ElliptaFluticasone/Vilanterol12$7,546
Tresiba Flextouch U-100Insulin Degludec11$6,688
Atorvastatin Calcium197$1,456
Bupropion XlBupropion Hcl39$1,286
Fluoxetine Hcl54$1,166
Levothyroxine Sodium89$901
Omeprazole62$894
Gabapentin50$885
Amlodipine Besylate163$873
Doxycycline Hyclate59$759
Rosuvastatin Calcium73$711
Losartan Potassium102$656
Potassium Chloride25$619

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$38$21,80821 claims
PfizerEliquis$80$19,60326 claims
GSKBreo Ellipta$129$7,54612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 555 adult health providers in Missouri.

Other adult health in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →